Cassava Sciences Inc. Looks to Continue to Trade Above its Annual-High Share Price Today

July 22, 2021 10:12:53

Cassava Sciences Inc. (NASDAQ:SAVA) traded today at a new 52-week high of $124.00. Approximately 1 million shares have changed hands today, as compared to an average 30-day volume of 3.2 million shares.

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer’s disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer’s disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer’s disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms.

In the past 52 weeks, Cassava Sciences Inc. share prices are bracketed by a low of $2.78 and a high of $124.00 and is now at $122.00, 4,288% above that low price.

Cassava Sciences Inc. (NASDAQ:SAVA) defies analysts with a current price ($122.00) 16.9% above its average consensus price target of $101.38.

Receive IBN Spotlights – “Bite Size” Small, Mid and Large-Cap Technical Indicator Alerts
To stay connected with our complimentary IBN Spotlights, please visit https://IBN.fm/connected

About InvestorBrandNetwork (IBN)
InvestorBrandNetwork (IBN) consists of 50+ trusted financial brands introduced to the investment public over the course of 15+ years. Through these brands, IBN provides (1) access to our Investor Press Release Wire Solutions via InvestorWire (IW) to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions via IW to ensure maximum impact; (4) full-scale distribution to an enormous social media audience that includes millions of followers; and (5) a full array of corporate communications solutions focused on the IBN Podcast Series. With a proven track record serving 500+ client partners, IBN is the key to a more effective market communication campaign.

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer